 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | HWH340 / WuXi AppTec, Humanwell Healthcare
Enrollment change, Trial completion date, Trial primary completion date, BRCA Biomarker, Metastases: Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Feb 17, 2020
P1, N=85, Recruiting, Sponsor: Hubei Biological Medicine Industrial Technology Institute Co., Ltd.
N=45 --> 85 | Trial completion date: Jun 2019 --> Sep 2021 | Trial primary completion date: Jun 2019 --> Mar 2021
- | HWH340 / WuXi AppTec, Humanwell Healthcare
New P1 trial, BRCA Biomarker, Metastases: Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Jan 30, 2018
P1, N=45, Recruiting, Sponsor: Hubei Biological Medicine Industrial Technology Institute Co., Ltd.